ReviewInternational journal of molecular sciences2026
Type 1 Diabetes Mellitus as a Model of Body Composition Transformation: Pathogenetic Unity of Combined Phenotypes.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The study of body composition (BC) is of increasing clinical and research relevance, as it provides a detailed characterization of metabolic status beyond traditional anthropometric indices such as body mass index (BMI). BC describes the quantitative ratio of fat mass (FM), lean mass (LM)-including skeletal muscle and internal organs-and bone mineral density (BMD). The pathogenetic mechanisms underlying specific BC phenotypes arise from a complex interplay of endocrine, metabolic, inflammatory, and genetic factors. Given the shared pathways involved in phenotype formation, the study of BC alterations across different diseases holds promise for predicting complications and identifying common therapeutic targets. This review aims to systematize current knowledge on combined BC phenotypes-sarcopenic obesity, osteosarcopenia, osteopenic obesity, and osteosarcopenic obesity-and to explore their pathogenetic unity, with particular emphasis on type 1 diabetes mellitus as a dynamic model of sequential phenotypic shifts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.